228 related articles for article (PubMed ID: 35137303)
1. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
3. Early diagnosis of Alzheimer's disease using combined features from voxel-based morphometry and cortical, subcortical, and hippocampus regions of MRI T1 brain images.
Gupta Y; Lee KH; Choi KY; Lee JJ; Kim BC; Kwon GR; ;
PLoS One; 2019; 14(10):e0222446. PubMed ID: 31584953
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous voxel-based magnetic susceptibility and morphometry analysis using magnetization-prepared spoiled turbo multiple gradient echo.
Kan H; Uchida Y; Arai N; Ueki Y; Aoki T; Kasai H; Kunitomo H; Hirose Y; Matsukawa N; Shibamoto Y
NMR Biomed; 2020 May; 33(5):e4272. PubMed ID: 32043682
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
[TBL] [Abstract][Full Text] [Related]
6. Disrupted Balance of Gray Matter Volume and Directed Functional Connectivity in Mild Cognitive Impairment and Alzheimer's Disease.
Xiong Y; Ye C; Sun R; Chen Y; Zhong X; Zhang J; Zhong Z; Chen H; Huang M
Curr Alzheimer Res; 2023; 20(3):161-174. PubMed ID: 37278043
[TBL] [Abstract][Full Text] [Related]
7. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Rhee SJ; Lee SY; Wang Y; Jahng GH
Neuroimage Clin; 2017; 16():429-438. PubMed ID: 28879084
[TBL] [Abstract][Full Text] [Related]
8. Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification.
Yoon D; Myong Y; Kim YG; Sim Y; Cho M; Oh BM; Kim S
Neuroimage; 2024 Aug; 296():120663. PubMed ID: 38843963
[TBL] [Abstract][Full Text] [Related]
9. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.
Hwang EJ; Kim HG; Kim D; Rhee HY; Ryu CW; Liu T; Wang Y; Jahng GH
Med Phys; 2016 Aug; 43(8):4718. PubMed ID: 27487889
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
[TBL] [Abstract][Full Text] [Related]
11. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
12. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
He P; Qu H; Cai M; Liu W; Gu X; Ma Q
Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease.
Waragai M; Okamura N; Furukawa K; Tashiro M; Furumoto S; Funaki Y; Kato M; Iwata R; Yanai K; Kudo Y; Arai H
J Neurol Sci; 2009 Oct; 285(1-2):100-8. PubMed ID: 19552926
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
Takao H; Amemiya S; Abe O;
J Alzheimers Dis; 2021; 83(1):281-290. PubMed ID: 34308908
[TBL] [Abstract][Full Text] [Related]
15. The role of visual rating and automated brain volumetry in early detection and differential diagnosis of Alzheimer's disease.
Mai Y; Cao Z; Zhao L; Yu Q; Xu J; Liu W; Liu B; Tang J; Luo Y; Liao W; Fang W; Ruan Y; Lei M; Mok VCT; Shi L; Liu J;
CNS Neurosci Ther; 2024 Apr; 30(4):e14492. PubMed ID: 37864441
[TBL] [Abstract][Full Text] [Related]
16. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
[TBL] [Abstract][Full Text] [Related]
17. Reliability of Changes in Brain Volume Determined by Longitudinal Voxel-Based Morphometry.
Takao H; Amemiya S; Abe O;
J Magn Reson Imaging; 2021 Aug; 54(2):609-616. PubMed ID: 33625755
[TBL] [Abstract][Full Text] [Related]
18. Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study.
Kim HW; Lee S; Yang JH; Moon Y; Lee J; Moon WJ
Korean J Radiol; 2023 Nov; 24(11):1131-1141. PubMed ID: 37899522
[TBL] [Abstract][Full Text] [Related]
19. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 18F-FDG PET and optimized voxel-based morphometry for detection of Alzheimer's disease: aging effect on diagnostic performance.
Matsunari I; Samuraki M; Chen WP; Yanase D; Takeda N; Ono K; Yoshita M; Matsuda H; Yamada M; Kinuya S
J Nucl Med; 2007 Dec; 48(12):1961-70. PubMed ID: 18006622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
